Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Varicella-zoster Vaccine”

280 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 280 results

Not applicableEnded earlyNCT00138255
What this trial is testing

Responses of Premature Infants to Measles-Mumps-Rubella (MMR) and Varicella Vaccines

Who this might be right for
MeaslesMumpsRubella+1 more
National Institute of Allergy and Infectious Diseases (NIAID) 32
Large-scale testing (Phase 3)Study completedNCT04334577
What this trial is testing

Study on Efficacy of Attenuated Zoster Vaccine, Live

Who this might be right for
Herpes Zoster
Changchun BCHT Biotechnology Co. 25,000
Not applicableLooking for participantsNCT07636044
What this trial is testing

Reduced Vaccine Response to HZ/su in SLE

Who this might be right for
Vaccine ReactionZosterSystemic Lupus Erythematosus
Seoul National University Hospital 80
Large-scale testing (Phase 3)Study completedNCT01991899
What this trial is testing

Study of Immunogenicity, Reactogenicity and Safety of the Combined Measles, Mumps and Rubella Vaccine Produced by Bio-Manguinhos/Fiocruz in Children 12-15 Months of Age, Followed by Tetraviral Vaccine in Children 15-18 Months.

Who this might be right for
MeaslesMumpsRubella+1 more
The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) 1,560
Large-scale testing (Phase 3)Study completedNCT00984295
What this trial is testing

Frozen ProQuad Administered Concomitantly Versus Nonconcomitantly With Other Pediatric Vaccines

Who this might be right for
MeaslesMumpsRubella+1 more
Merck Sharp & Dohme LLC 1,913
Large-scale testing (Phase 3)UnknownNCT05015686
What this trial is testing

Safety and Immunogenicity of Live Attenuated Varicella Vaccine in Healthy Population Aged ≥13 Years Old

Who this might be right for
Varicella
Sinovac (Dalian) Vaccine Technology Co., Ltd. 2,400
Testing effectiveness (Phase 2)Active Not RecruitingNCT06581575
What this trial is testing

Evaluate JCXH-105, an srRNA-based Herpes Zoster Vaccine

Who this might be right for
Herpes Zoster (HZ)Infectious DiseasesShingles
Immorna Biotherapeutics, Inc. 467
Testing effectiveness (Phase 2)Looking for participantsNCT06932523
What this trial is testing

Evaluate the Safety of Recombinant Herpes Zoster Vaccine for Healthy Individuals

Who this might be right for
Herpes Zoster (HZ)
Shanghai Institute Of Biological Products 645
Early research (Phase 1)Study completedNCT03820414
What this trial is testing

Safety, Tolerability, and Immunogenicity of CRV-101 in Healthy Adult Subjects

Who this might be right for
Herpes ZosterVaricella Zoster
Curevo Inc 90
Large-scale testing (Phase 3)Study completedNCT01777321
What this trial is testing

Safety and Immunogenicity Study of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine GSK1437173A When Administered Subcutaneously Intramuscularly in Adults Aged ≥50 Years

Who this might be right for
Herpes Zoster
GlaxoSmithKline 60
Post-approval studies (Phase 4)Looking for participantsNCT05559671
What this trial is testing

Safety of the Herpes Zoster Subunit Vaccine in Lupus

Who this might be right for
Systemic Lupus Erythematosus
NYU Langone Health 224
Not applicableActive Not RecruitingNCT05811754
What this trial is testing

Safety of Herpes Zoster Subunit (HZ/su) Vaccine During Pregnancy in Adult Women With Immunocompromised Conditions

Who this might be right for
Herpes Zoster
GlaxoSmithKline 2,844
Not applicableStudy completedNCT02704572
What this trial is testing

Optimal Timing of Zoster Vaccine After Zoster Illness

Who this might be right for
Shingles
Seoul National University Hospital 60
Early research (Phase 1)Study completedNCT03121638
What this trial is testing

Safety Study of NBP608 in Healthy Adult Volunteers

Who this might be right for
Varicella ZosterImmunization; Infection
SK Chemicals Co., Ltd. 150
Testing effectiveness (Phase 2)Study completedNCT03702231
What this trial is testing

Response to the SHINGRIX Varicella Zoster Virus (VZV) Vaccine in Chronic Lymphocytic Leukemia (CLL) and CLL Treated With Bruton's Tyrosine Kinase Inhibitor (BTK-I)

Who this might be right for
Safety and TolerabilityCompare SHINGRIX Vaccine Response RatesChronic Lymphocytic Leukemia (CLL)+1 more
National Heart, Lung, and Blood Institute (NHLBI) 116
Early research (Phase 1)Ended earlyNCT05701800
What this trial is testing

Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1468 in Healthy Adults ≥50 Years of Age

Who this might be right for
Herpes Zoster
ModernaTX, Inc. 659
Large-scale testing (Phase 3)Study completedNCT05158777
What this trial is testing

Safety and Immunogenicity of Live Attenuated Varicella Vaccine in Healthy Population Aged ≥13 Years Old

Who this might be right for
Varicella
Shanghai Institute Of Biological Products 2,480
Large-scale testing (Phase 3)Study completedNCT04176939
What this trial is testing

Test GlaxoSmithKline's (GSK) Herpes Zoster (HZ) Subunit Vaccine's Long-term Immune Response in Previously Vaccinated Kidney Transplant Adults and Then to Test if 2 Additional Doses of the Vaccine Are Safe and Able to Generate an Immune Response

Who this might be right for
Herpes Zoster
GlaxoSmithKline 68
Large-scale testing (Phase 3)Study completedNCT02979639
What this trial is testing

Study to Evaluate the Impact of Reactogenicity on Quality of Life (QoL), After Administration of GlaxoSmithKline (GSK) Biologicals' Candidate Herpes Zoster Subunit (HZ/su) Vaccine (GSK1437173A) in Adults ≥ 50 Years of Age

Who this might be right for
Herpes Zoster
GlaxoSmithKline 404
Very early researchStudy completedNCT03771157
What this trial is testing

Serologic Response to SHINGRIX Vaccine in Patients With CLL and WM Treated With BTK Inhibitors

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)Waldenstrom Macroglobulinemia (WM)
University of Rochester 33
Next Page